Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19597 | 433 | 26.9 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BUPROPION | Author keyword | 33 | 21% | 33% | 142 |
2 | HYDROXYBUPROPION | Author keyword | 12 | 63% | 3% | 12 |
3 | WELLBUTRIN | Author keyword | 7 | 67% | 1% | 6 |
4 | BUPROPION HYDROCHLORIDE | Author keyword | 4 | 44% | 2% | 7 |
5 | ZYBAN | Author keyword | 4 | 46% | 1% | 6 |
6 | THREOHYDROBUPROPION | Author keyword | 3 | 100% | 1% | 3 |
7 | ZYBAN R | Author keyword | 3 | 100% | 1% | 3 |
8 | BUPROPION METABOLITE | Author keyword | 1 | 100% | 0% | 2 |
9 | NASAL INSUFFLATION | Author keyword | 1 | 100% | 0% | 2 |
10 | WELLBUTRIN R | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUPROPION | 33 | 21% | 33% | 142 | Search BUPROPION | Search BUPROPION |
2 | HYDROXYBUPROPION | 12 | 63% | 3% | 12 | Search HYDROXYBUPROPION | Search HYDROXYBUPROPION |
3 | WELLBUTRIN | 7 | 67% | 1% | 6 | Search WELLBUTRIN | Search WELLBUTRIN |
4 | BUPROPION HYDROCHLORIDE | 4 | 44% | 2% | 7 | Search BUPROPION+HYDROCHLORIDE | Search BUPROPION+HYDROCHLORIDE |
5 | ZYBAN | 4 | 46% | 1% | 6 | Search ZYBAN | Search ZYBAN |
6 | THREOHYDROBUPROPION | 3 | 100% | 1% | 3 | Search THREOHYDROBUPROPION | Search THREOHYDROBUPROPION |
7 | ZYBAN R | 3 | 100% | 1% | 3 | Search ZYBAN+R | Search ZYBAN+R |
8 | BUPROPION METABOLITE | 1 | 100% | 0% | 2 | Search BUPROPION+METABOLITE | Search BUPROPION+METABOLITE |
9 | NASAL INSUFFLATION | 1 | 100% | 0% | 2 | Search NASAL+INSUFFLATION | Search NASAL+INSUFFLATION |
10 | WELLBUTRIN R | 1 | 100% | 0% | 2 | Search WELLBUTRIN+R | Search WELLBUTRIN+R |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SICKNESS LIKE REACTION | 17 | 79% | 3% | 11 |
2 | MAJOR BASIC METABOLITES | 11 | 100% | 1% | 6 |
3 | HYDROXYBUPROPION | 3 | 50% | 1% | 4 |
4 | NASAL INSUFFLATION | 3 | 50% | 1% | 4 |
5 | WELLBUTRIN | 1 | 100% | 0% | 2 |
6 | CHRONIC BUPROPION | 1 | 50% | 0% | 1 |
7 | HYDROXYBUTYRIC ACID GHBA | 1 | 50% | 0% | 1 |
8 | MIRTAZAPINE OVERDOSE | 1 | 50% | 0% | 1 |
9 | PREGABALIN ABUSE | 1 | 50% | 0% | 1 |
10 | TEENAGER | 1 | 18% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Bupropion - A review of its use in the management of major depressive disorder | 2008 | 53 | 55 | 56% |
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent | 2006 | 97 | 184 | 44% |
Risks and Benefits of Bupropion Treatment in Schizophrenia: A Systematic Review of the Current Literature | 2013 | 7 | 76 | 38% |
The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder | 2011 | 18 | 55 | 31% |
Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations | 2005 | 72 | 46 | 59% |
Bupropion: pharmacology and therapeutic applications | 2006 | 68 | 142 | 38% |
Acute psychosis following sustained release bupropion overdose | 2005 | 9 | 7 | 100% |
A case of prolonged seizure activity after combined use of bupropion and clomipramine | 2004 | 3 | 8 | 88% |
Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity? | 2007 | 17 | 66 | 45% |
Bupropion: pharmacological and clinical profile in smoking cessation | 2003 | 17 | 56 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACEUT BIOMED ADM SCI | 1 | 25% | 0.7% | 3 |
2 | AGENCIA SALUD PUBL BARCELONA ASPB | 1 | 33% | 0.5% | 2 |
3 | PROGRAMA CLIN DEP | 1 | 33% | 0.5% | 2 |
4 | SERV PSIQUIATRIA CAS VALL HEBRON | 1 | 33% | 0.5% | 2 |
5 | UNITAT PSIQUIATRIA GERIATR SAGRAT COR | 1 | 33% | 0.5% | 2 |
6 | BOISE VET AFFAIRS MED | 1 | 50% | 0.2% | 1 |
7 | CARDIOVASC PHARMACOL HYPERTENS | 1 | 50% | 0.2% | 1 |
8 | CNRSFRE 2463 | 1 | 50% | 0.2% | 1 |
9 | EMERGENCY MEDCLIN PHARMACOL PROGRAM | 1 | 50% | 0.2% | 1 |
10 | MDX | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165409 | EFAVIRENZ//CYP2B6//NEVIRAPINE |
2 | 0.0000098818 | NORFLUOXETINE//FLUVOXAMINE//CITALOPRAM |
3 | 0.0000089260 | SEXUAL DYSFUNCTION//HYPERPROLACTINEMIA//HYPERPROLACTINAEMIA |
4 | 0.0000080364 | VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM |
5 | 0.0000077471 | LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM |
6 | 0.0000074579 | NORTRIPTYLINE//DESMETHYLCLOMIPRAMINE//DOXEPIN |
7 | 0.0000066866 | PSYCHOBIOL SECT//BENZTROPINE ANALOGS//GBR 12909 |
8 | 0.0000065010 | INTRAMOLECULAR BARBIER REACTION//NOREPINEPHRINE POTENTIATOR//REDUCTIVE N METHYLATION |
9 | 0.0000061511 | SMOKING CESSATION//NICOTINE REPLACEMENT THERAPY//VARENICLINE |
10 | 0.0000057936 | DRL BEHAVIOR//DRL 72 S SCHEDULE//BEHAVIORAL SCREEN |